0001209191-19-003805.txt : 20190115
0001209191-19-003805.hdr.sgml : 20190115
20190115185805
ACCESSION NUMBER: 0001209191-19-003805
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190101
FILED AS OF DATE: 20190115
DATE AS OF CHANGE: 20190115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Holden Stuart
CENTRAL INDEX KEY: 0001763999
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38079
FILM NUMBER: 19527918
MAIL ADDRESS:
STREET 1: C/O UROGEN PHARMA LTD.
STREET 2: 9 HA'TA'ASIYA STREET
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UroGen Pharma Ltd.
CENTRAL INDEX KEY: 0001668243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
BUSINESS PHONE: 972 9 770 7601
MAIL ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
3/A
1
doc3a.xml
FORM 3/A SUBMISSION
X0206
3/A
2019-01-01
2019-01-10
0
0001668243
UroGen Pharma Ltd.
URGN
0001763999
Holden Stuart
C/O UROGEN PHARMA LTD.
9 HA?TA?ASIYA STREET
RA?ANANA
L3
4365007
ISRAEL
1
0
0
0
Stock Option (right to buy)
5.94
2022-12-10
Ordinary Shares
48000
D
33.33% of the shares underlying the stock option vested on each of December 10, 2016, December 10, 2017 and December 10, 2018.
This option grant was inadvertently omitted from the Reporting Person's initial Form 3.
/s/ Peter Pfreundschuh, Attorney-in-Fact
2019-01-15